These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 22520042)

  • 1. [Advances in uro-oncology «Oncoforum»: the best of 2011].
    Gómez-Veiga F; Alcaraz-Asensio A; Burgos-Revilla J; Cózar-Olmo J
    Actas Urol Esp; 2012 Oct; 36(9):507-14. PubMed ID: 22520042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advances in uro-oncology "OncoForum": the best of 2013.
    Gómez-Veiga F; Alcaraz-Asensio A; Burgos-Revilla J; Cózar-Olmo J
    Actas Urol Esp; 2014 Oct; 38(8):491-8. PubMed ID: 24731526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Advances in uro-oncology "OncoForum": the best of 2010].
    Gómez-Veiga F; Alcaraz-Asensio A; Burgos-Revilla J; Cózar-Olmo JM
    Actas Urol Esp; 2011 Jun; 35(6):315-24. PubMed ID: 21453988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Developments in urologic oncology 'OncoForum': The best of 2014.
    Gómez-Veiga F; Alcaraz-Asensio A; Burgos-Revilla J; Cózar-Olmo J
    Actas Urol Esp; 2015 Jun; 39(5):271-8. PubMed ID: 25770399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Developments in urologic oncology «OncoForum»: The best of 2015.
    Gómez-Veiga F; Alcaraz-Asensio A; Burgos-Revilla J; Cózar-Olmo J
    Actas Urol Esp; 2016; 40(6):361-9. PubMed ID: 27061663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances in urologic oncology "OncoUrology Forum Special Edition": The best of 2020.
    Gómez-Veiga F; Alcaraz-Asensio A; Burgos-Revilla JM; Cózar-Olmo FJ
    Actas Urol Esp (Engl Ed); 2022 May; 46(4):214-222. PubMed ID: 34844900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Update urooncology: news with clinical relevance from major scientific meetings 2012].
    Hegele A; Skrobek L; Schrader AJ
    Aktuelle Urol; 2012 Dec; 43(6):376-87. PubMed ID: 23254351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Developments in urologic oncology "OncoForum": The best of 2017.
    Gómez-Veiga F; Alcaraz-Asensio A; Burgos-Revilla J; Cózar-Olmo J
    Actas Urol Esp (Engl Ed); 2018 Oct; 42(8):488-498. PubMed ID: 29935800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The history and future of the Urologic Oncology Study Group (UOSG) of the Japan Clinical Oncology Group (JCOG).
    Tobisu K
    Jpn J Clin Oncol; 2012 May; 42(5):363-7. PubMed ID: 22450928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Developments in urologic oncology «OncoForum»: The best of 2016.
    Gómez-Veiga F; Alcaraz-Asensio A; Burgos-Revilla J; Cózar-Olmo JM
    Actas Urol Esp; 2017 Nov; 41(9):543-551. PubMed ID: 28734596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radical prostatectomy improves progression-free and cancer-specific survival in men with lymph node positive prostate cancer in the prostate-specific antigen era: a confirmatory study.
    Steuber T; Budäus L; Walz J; Zorn KC; Schlomm T; Chun F; Ahyai S; Fisch M; Sauter G; Huland H; Graefen M; Haese A
    BJU Int; 2011 Jun; 107(11):1755-61. PubMed ID: 20942833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of provider volume on outcomes from urological cancer therapy.
    Joudi FN; Konety BR
    J Urol; 2005 Aug; 174(2):432-8. PubMed ID: 16006859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Penile cancer in 2010: update from the Oncology Committee of the French Association of Urology: external genital organs group (CCAFU-OGE)].
    Souillac I; Avances C; Camparo P; Culine S; Durand X; Haie-Meder C; Sebe P; Soulie M; Rigaud J
    Prog Urol; 2011 Dec; 21(13):909-16. PubMed ID: 22118355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances in urologic oncology "OncoForum": The best of 2019.
    Gómez-Veiga F; Alcaraz Asensio A; Burgos Revilla J; Cózar Olmo J
    Actas Urol Esp (Engl Ed); 2020 Nov; 44(9):586-596. PubMed ID: 32948345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Results of radical cystectomy for management of invasive bladder cancer with special reference to prognostic factors and quality of life depending on the type of urinary diversion].
    Słojewski M
    Ann Acad Med Stetin; 2000; 46():217-29. PubMed ID: 11712306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stage-specific impact of pelvic lymph node dissection on survival in patients with non-metastatic bladder cancer treated with radical cystectomy.
    Abdollah F; Sun M; Schmitges J; Djahangirian O; Tian Z; Jeldres C; Perrotte P; Shariat SF; Montorsi F; Karakiewicz PI
    BJU Int; 2012 Apr; 109(8):1147-54. PubMed ID: 21883849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evidence-based radiotherapy in the treatment of operable breast cancer: results in the 1990-ies].
    Fodor J; Polgár C; Németh G
    Orv Hetil; 2000 Jul; 141(28):1551-5. PubMed ID: 10957865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maximizing outcomes in genitourinary cancers across the treatment continuum.
    Fitzpatrick JM; Bellmunt J; Dreicer R; Fleshner NE; Logothetis CJ; Moul JW; Tombal B; Zlotta A
    BJU Int; 2011 Apr; 107 Suppl 2():1-12. PubMed ID: 21382149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of the lymph nodes in penile cancer.
    Heyns CF; Fleshner N; Sangar V; Schlenker B; Yuvaraja TB; van Poppel H
    Urology; 2010 Aug; 76(2 Suppl 1):S43-57. PubMed ID: 20691885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Prostate cancer Intervention Versus Observation Trial:VA/NCI/AHRQ Cooperative Studies Program #407 (PIVOT): design and baseline results of a randomized controlled trial comparing radical prostatectomy to watchful waiting for men with clinically localized prostate cancer.
    Wilt TJ; Brawer MK; Barry MJ; Jones KM; Kwon Y; Gingrich JR; Aronson WJ; Nsouli I; Iyer P; Cartagena R; Snider G; Roehrborn C; Fox S
    Contemp Clin Trials; 2009 Jan; 30(1):81-7. PubMed ID: 18783735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.